A Feng, a patient from Zhejiang, has been suffering from liposarcoma for more than 9 years. During this period, he underwent several surgeries, combined with chemotherapy, radiotherapy, targeted therapy, and immunotherapy , and the tumor recurred and progressed several times. Now the tumor has extended from the retroperitoneum to the thoracic mediastinum. Ah Feng has experienced symptoms such as difficulty in eating and restricted breathing, and her quality of life has been extremely reduced. The mediastinum is the location of many important organ structures of the human body, including pericardium , esophagus, thoracic aorta, trachea, etc. It is equivalent to a lifeline. Once the tumor compresses and bleeds, it will directly bring life danger.
For this reason, Lu Weiqi, director of the General Surgery Department of Jinshan Hospital Affiliated to Fudan University, led the retroperitoneal tumor surgery team to conduct a detailed assessment of the status of the tumor. After full communication with the patient and family, he decided to launch an "attack" on the tumor.
The operation lasted nearly 10 hours. The general surgery team led by Lu Weiqi worked closely with the Thoracic Surgery Department, operating room, anesthesia department, and blood transfusion department of Zhongshan Hospital to successfully completely remove the tumor that invaded the pericardium and part of the lungs. At the same time, the entire stomach, part of the liver, left colon, pancreatic body, and part of the small intestine were removed. The
surgical team innovatively used biological repair materials based on bovine pericardium to repair the pericardium, achieving the perfect unity of tissue compatibility and safety.
After the operation, through the joint efforts of the surgical team, intensive care team, relevant medical technology departments, and nursing team, the complications were dealt with in a timely and effective manner. The patient Afeng successfully passed through the trauma, bleeding, infection, respiratory failure, and nutrition challenges, gradually recovered, and was successfully discharged from the hospital recently.
It is understood that Professor Lu Weiqi has been engaged in clinical work in the General Surgery Department of Zhongshan Hospital for a long time and has rich clinical experience. In 2009, the country's first multidisciplinary team for retroperitoneal soft tissue tumors was established. It has high attainments in this field and ranks among the best in the country in terms of number of treated cases, number of surgeries, and therapeutic effects. In 2022, he was hired as the director of the General Surgery Department of Jinshan Hospital, bringing advanced and standardized treatment concepts and methods for retroperitoneal tumors and peritoneal cancer to Jinshan Hospital.
reporter | Yang Huicong Zhu Lei
correspondent | Zhang Huisheng
editor | Shen Yanfei
editor | Yu Luoyin
